Cargando…

Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia

BACKGROUND: Unsuppressed viral load in patients on antiretroviral (ARV) therapy occurs when treatment fails to suppress a patient’s viral load, and is associated with decreased survival and increased HIV transmission. Identifying the level of unsuppressed viral load with its associated factors has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Waju, Birhanu, Dube, Lamessa, Ahmed, Muktar, Assefa, Semira Shimeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131002/
https://www.ncbi.nlm.nih.gov/pubmed/34017201
http://dx.doi.org/10.2147/HIV.S304653
_version_ 1783694626993995776
author Waju, Birhanu
Dube, Lamessa
Ahmed, Muktar
Assefa, Semira Shimeles
author_facet Waju, Birhanu
Dube, Lamessa
Ahmed, Muktar
Assefa, Semira Shimeles
author_sort Waju, Birhanu
collection PubMed
description BACKGROUND: Unsuppressed viral load in patients on antiretroviral (ARV) therapy occurs when treatment fails to suppress a patient’s viral load, and is associated with decreased survival and increased HIV transmission. Identifying the level of unsuppressed viral load with its associated factors has benefits in controlling transmission and reducing burden. Therefore, this study aimed to assess unsuppressed viral load (>1,000 copies/mL) and associated factors among HIV patients taking first-line antiretroviral treatment at public health facilities in Jimma, Ethiopia. METHODS: A facility-based cross-sectional study was conducted on 669 patients on first-line ARV therapy (at least 6 months) in public health facilities in Jimma. Sociodemographic, treatment, clinical, immunological, and viral load data were extracted from medical records, entered into EpiData 3.1, and analyzed with SPSS 20. Multivariate logistic regression analysis was performed to identify factors independently associated with viral nonsuppression, considering a 95% CI with P<0.05 statistically significant. RESULTS: Among the participants, 258 (38.6%) were aged 25–34 years. Median age was 35 years. Prevalence of unsuppressed viral load was 20.3%. Risk of unsuppressed viral loads was 91% lower among ARV therapy patients who had been taking ARV therapy <2 years (AOR 0.09, 95% CI 0.01–0.83), lower baseline BMI (AOR 4.44, 95% CI 1.56–12.64), lower baseline CD4 (AOR 2.76, 95% CI 1.45–5.29), poor adherence to ARV therapy medication (AOR 3.19, 95% CI 1.29–7.89), and immunological failure (AOR 4.26, 95% CI 2.56–7.09) were the independent predictors of unsuppressed viral load. CONCLUSION: This study revealed that there is a high level of virological failure among adult HIV patients, and confirms the need to develop close follow-up strategies of targeted interventions for patients in care who are at high risk of unsuppressed viral load.
format Online
Article
Text
id pubmed-8131002
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81310022021-05-19 Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia Waju, Birhanu Dube, Lamessa Ahmed, Muktar Assefa, Semira Shimeles HIV AIDS (Auckl) Original Research BACKGROUND: Unsuppressed viral load in patients on antiretroviral (ARV) therapy occurs when treatment fails to suppress a patient’s viral load, and is associated with decreased survival and increased HIV transmission. Identifying the level of unsuppressed viral load with its associated factors has benefits in controlling transmission and reducing burden. Therefore, this study aimed to assess unsuppressed viral load (>1,000 copies/mL) and associated factors among HIV patients taking first-line antiretroviral treatment at public health facilities in Jimma, Ethiopia. METHODS: A facility-based cross-sectional study was conducted on 669 patients on first-line ARV therapy (at least 6 months) in public health facilities in Jimma. Sociodemographic, treatment, clinical, immunological, and viral load data were extracted from medical records, entered into EpiData 3.1, and analyzed with SPSS 20. Multivariate logistic regression analysis was performed to identify factors independently associated with viral nonsuppression, considering a 95% CI with P<0.05 statistically significant. RESULTS: Among the participants, 258 (38.6%) were aged 25–34 years. Median age was 35 years. Prevalence of unsuppressed viral load was 20.3%. Risk of unsuppressed viral loads was 91% lower among ARV therapy patients who had been taking ARV therapy <2 years (AOR 0.09, 95% CI 0.01–0.83), lower baseline BMI (AOR 4.44, 95% CI 1.56–12.64), lower baseline CD4 (AOR 2.76, 95% CI 1.45–5.29), poor adherence to ARV therapy medication (AOR 3.19, 95% CI 1.29–7.89), and immunological failure (AOR 4.26, 95% CI 2.56–7.09) were the independent predictors of unsuppressed viral load. CONCLUSION: This study revealed that there is a high level of virological failure among adult HIV patients, and confirms the need to develop close follow-up strategies of targeted interventions for patients in care who are at high risk of unsuppressed viral load. Dove 2021-05-14 /pmc/articles/PMC8131002/ /pubmed/34017201 http://dx.doi.org/10.2147/HIV.S304653 Text en © 2021 Waju et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Waju, Birhanu
Dube, Lamessa
Ahmed, Muktar
Assefa, Semira Shimeles
Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia
title Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia
title_full Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia
title_fullStr Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia
title_full_unstemmed Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia
title_short Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia
title_sort unsuppressed viral load level in public health facilities: nonvirological predictors among adult antiretroviral therapy users in southwestern ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131002/
https://www.ncbi.nlm.nih.gov/pubmed/34017201
http://dx.doi.org/10.2147/HIV.S304653
work_keys_str_mv AT wajubirhanu unsuppressedviralloadlevelinpublichealthfacilitiesnonvirologicalpredictorsamongadultantiretroviraltherapyusersinsouthwesternethiopia
AT dubelamessa unsuppressedviralloadlevelinpublichealthfacilitiesnonvirologicalpredictorsamongadultantiretroviraltherapyusersinsouthwesternethiopia
AT ahmedmuktar unsuppressedviralloadlevelinpublichealthfacilitiesnonvirologicalpredictorsamongadultantiretroviraltherapyusersinsouthwesternethiopia
AT assefasemirashimeles unsuppressedviralloadlevelinpublichealthfacilitiesnonvirologicalpredictorsamongadultantiretroviraltherapyusersinsouthwesternethiopia